Immuron (IMRN) Non-Current Debt (2016 - 2020)
Immuron (IMRN) posted quarterly Non-Current Debt of $935.15 for Q4 2020, down 99.05% year-on-year from $98120.0 in Q1 2020, and down 99.05% on a QoQ basis from $98120.0 in Q4 2019.
Immuron (IMRN) Non-Current Debt (2016 - 2020) Analysis & Trends
Immuron (IMRN) has reported Non-Current Debt for 4 consecutive years, with $935.15 the latest figure, recorded in Q4 2020.
- Quarterly Non-Current Debt fell 99.05% year-over-year to $935.15 in Q4 2020, while the trailing twelve-month figure through Dec 2020 was $935.15 (down 99.05% YoY) and the FY2020 annual result came in at $935.15, down 99.05% from the prior year.
- Non-Current Debt declined to $935.15 in Q4 2020 per IMRN's latest filing, from $98120.0 in the prior quarter.
- Over the last five years, Non-Current Debt for IMRN reached as high as $545485.8 in Q4 2016 and fell as low as $935.15 in Q4 2020.
- A 4-year average of $160260.0 and a median of $98775.4 in 2017 frame the typical range for Non-Current Debt.
- Annual changes were most pronounced in 2017 — Non-Current Debt sank 81.89% — and 2020, when it slumped 99.05%.
- Year by year, Non-Current Debt stood at $545485.8 in 2016, then plunged by 81.89% to $98775.4 in 2017, then slipped by 0.66% to $98120.0 in 2019, then sank by 99.05% to $935.15 in 2020.
- According to Business Quant data, Non-Current Debt over the past three periods registered $935.15, $98120.0, and $98775.4 for Q4 2020, Q4 2019, and Q4 2017 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 105.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 842.92 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.99 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Immuron | 270.20 Mn | 258.54 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2020 | 935.15 |
| Dec 31, 2019 | 98,120.00 |
| Dec 31, 2017 | 98,775.41 |
| Sep 28, 2017 | 98,775.41 |
| Aug 31, 2017 | 139,864.00 |
| Jun 30, 2017 | 139,864.00 |
| Dec 31, 2016 | 545,485.82 |